English

ESSENTIAL THERAPEUTICS INC

EDGAR

Quarterly report amendment (10-Q/A) · filed 2003-11-12

34 filing records in this dataset, filed from 1996-08-01 to 2003-11-12. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.03 million USD

2003-06-30 · USD

Exact inputs and evidence

Revenue: 1030000 USD Source

Operating margin

-342.52%

2003-06-30 · %

Exact inputs and evidence

Operating Income: -3528000 USD Source
Revenue: 1030000 USD Source

Operating cash flow

-8.71 million USD

2003-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -16039000 USD Source
Operating Cash Flow: -7330000 USD Source

Free cash flow

-8.72 million USD

2003-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -16039000 USD Source
Operating Cash Flow: -7330000 USD Source
Capital Expenditure: 430000 USD Source
Capital Expenditure: 416000 USD Source

Cash and cash equivalents: 2.15 million USD 2003-06-30 Source
Exact value

2145000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

6.98 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Revenue: 1837000 USD · 2002-07-01 – 2002-09-30 Source
Revenue: 8673000 USD · 2002-01-01 – 2002-12-31 Source
Revenue: 7217000 USD · 2002-01-01 – 2002-09-30 Source
Revenue: 2654000 USD · 2003-01-01 – 2003-03-31 Source
Revenue: 1030000 USD · 2003-04-01 – 2003-06-30 Source

Net income

-23.7 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Net income: -5079000 USD · 2002-07-01 – 2002-09-30 Source
Net income: -41202000 USD · 2002-01-01 – 2002-12-31 Source
Net income: -34273000 USD · 2002-01-01 – 2002-09-30 Source
Net income: -8502000 USD · 2003-01-01 – 2003-03-31 Source
Net income: -3155000 USD · 2003-04-01 – 2003-06-30 Source

Operating cash flow

-24.1 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Operating cash flow: -17520000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -13360000 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -21453000 USD · 2002-01-01 – 2002-12-31 Source
Operating cash flow: -17520000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -7330000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: -16039000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: -7330000 USD · 2003-01-01 – 2003-03-31 Source

Capital expenditure

3.05 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Capital expenditure: 1693000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 997000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 3612000 USD · 2002-01-01 – 2002-12-31 Source
Capital expenditure: 1693000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 416000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 430000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 416000 USD · 2003-01-01 – 2003-03-31 Source

Free cash flow

-27.2 million USD

2002-07-01 – 2003-06-30

Exact inputs and evidence

Operating cash flow: -17520000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -13360000 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -21453000 USD · 2002-01-01 – 2002-12-31 Source
Operating cash flow: -17520000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -7330000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: -16039000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: -7330000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 1693000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 997000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 3612000 USD · 2002-01-01 – 2002-12-31 Source
Capital expenditure: 1693000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 416000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 430000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 416000 USD · 2003-01-01 – 2003-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2003-11-12.

Financial data available through: 2002-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2002-12-31
Operating income: 9 of 11 periods available· newest 2002-12-31
Net income: 9 of 11 periods available· newest 2002-12-31
Operating cash flow: 9 of 11 periods available· newest 2002-12-31
Capital expenditure: 9 of 11 periods available· newest 2002-12-31
Total assets: 8 of 11 periods available· newest 2002-12-31
liabilities: No compatible figures in this window
Current assets: 8 of 11 periods available· newest 2002-12-31
Current liabilities: 8 of 11 periods available· newest 2002-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2002-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-18.7%

Prior period

USD 10.67 million

2001-01-01 – 2001-12-31
Current period

USD 8.67 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

8673000 − 10666000 = -1993000 USD

10666000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
8673000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Year-over-year change in Revenue: -1993000 USD Concept: fundies:Revenue Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 8673000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#5457 Input fundies:Revenue: 10666000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#5457
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 13.28 million

Prior period

−USD 27.93 million

2001-01-01 – 2001-12-31
Current period

−USD 41.2 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

-41202000 − -27925000 = -13277000 USD

-27925000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
-41202000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Year-over-year change in Net income: -13277000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -41202000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7129 Input fundies:NetIncome: -27925000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7129
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 11.47 million

Prior period

−USD 9.98 million

2001-01-01 – 2001-12-31
Current period

−USD 21.45 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

-21453000 − -9983000 = -11470000 USD

-9983000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
-21453000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Year-over-year change in Operating cash flow: -11470000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -21453000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410 Input fundies:OperatingCashFlow: -9983000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+443.2%

Prior period

USD 665,000

2001-01-01 – 2001-12-31
Current period

USD 3.61 million

2002-01-01 – 2002-12-31

Exact inputs and evidence

3612000 − 665000 = 2947000 USD

665000 USD · 2001-01-01 – 2001-12-31
Inspect prior input Prior source
3612000 USD · 2002-01-01 – 2002-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Year-over-year change in Capital expenditure: 2947000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 3612000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564 Input fundies:CapitalExpenditure: 665000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2002-01-01 – 2002-12-31

Revenue USD 8.67 million 100% of revenue
Operating costs Derived USD 51.05 million 589% of revenue
Operating income −USD 42.38 million −489% of revenue
Tax, interest and other Derived −USD 1.17 million −14% of revenue
Net income −USD 41.2 million −475% of revenue

Cash

Operating cash flow −USD 21.45 million −247% of revenue
Capital expenditure USD 3.61 million 42% of revenue
Free cash flow Derived −USD 25.07 million −289% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Not shown: operating income or net income is not reported.
1995 Operating loss: operating costs were 170% of revenue.
1996 Operating loss: operating costs were 121% of revenue.
1997 Operating loss: operating costs were 147% of revenue.
1998 Operating loss: operating costs were 204% of revenue.
1999 Operating loss: operating costs were 225% of revenue.
2000 Operating loss: operating costs were 348% of revenue.
2001 Operating loss: operating costs were 368% of revenue.
2002 Operating loss: operating costs were 589% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	0	7003000 Derived	-7003000	31000 Derived	-7034000	-6941000 Derived	Source 1994-01-01 – 1994-12-31: 0 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -7003000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -7034000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -6249000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 692000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	4985000	8480000 Derived	-3495000	21000 Derived	-3516000	-1363000 Derived	Source 1995-01-01 – 1995-12-31: 4985000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -3495000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -3516000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -1215000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 148000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	11273000	13606000 Derived	-2333000	-1663000 Derived	-670000	-1392000 Derived	Source 1996-01-01 – 1996-12-31: 11273000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -2333000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -670000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: 4387000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 5779000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	14894000	21968000 Derived	-7074000	-2472000 Derived	-4602000	-6288000 Derived	Source 1997-01-01 – 1997-12-31: 14894000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -7074000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -4602000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -2586000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 3702000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	11181000	22777000 Derived	-11596000	-1838000 Derived	-9758000	-10677000 Derived	Source 1998-01-01 – 1998-12-31: 11181000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -11596000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -9758000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -7588000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 3089000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	9448000	21244000 Derived	-11796000	-1050000 Derived	-10746000	-7777000 Derived	Source 1999-01-01 – 1999-12-31: 9448000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -11796000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -10746000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -7304000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 473000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	5864000	20435000 Derived	-14571000	-626000 Derived	-13945000	-12304000 Derived	Source 2000-01-01 – 2000-12-31: 5864000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -14571000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -13945000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -11525000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 779000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	10666000	39265000 Derived	-28599000	-674000 Derived	-27925000	-10648000 Derived	Source 2001-01-01 – 2001-12-31: 10666000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -28599000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -27925000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -9983000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 665000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	8673000	51049000 Derived	-42376000	-1174000 Derived	-41202000	-25065000 Derived	Source 2002-01-01 – 2002-12-31: 8673000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -42376000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -41202000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -21453000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 3612000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 8.7M 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	0	Revenue: 0 Open source
19951995-12-31	Revenue	4985000	Revenue: 4985000 Open source
19961996-12-31	Revenue	11273000	Revenue: 11273000 Open source
19971997-12-31	Revenue	14894000	Revenue: 14894000 Open source
19981998-12-31	Revenue	11181000	Revenue: 11181000 Open source
19991999-12-31	Revenue	9448000	Revenue: 9448000 Open source
20002000-12-31	Revenue	5864000	Revenue: 5864000 Open source
20012001-12-31	Revenue	10666000	Revenue: 10666000 Open source
20022002-12-31	Revenue	8673000	Revenue: 8673000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-18.7% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19951995-12-31	Year over year	No prior comparable period	Revenue: 4985000 Open source Revenue: 0 Open source
19961996-12-31	Year over year	126.1%	Revenue: 11273000 Open source Revenue: 4985000 Open source
19971997-12-31	Year over year	32.1%	Revenue: 14894000 Open source Revenue: 11273000 Open source
19981998-12-31	Year over year	-24.9%	Revenue: 11181000 Open source Revenue: 14894000 Open source
19991999-12-31	Year over year	-15.5%	Revenue: 9448000 Open source Revenue: 11181000 Open source
20002000-12-31	Year over year	-37.9%	Revenue: 5864000 Open source Revenue: 9448000 Open source
20012001-12-31	Year over year	81.9%	Revenue: 10666000 Open source Revenue: 5864000 Open source
20022002-12-31	Year over year	-18.7%	Revenue: 8673000 Open source Revenue: 10666000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -488.6% 2002

Net margin -475.1% 2002

Free cash flow margin -289% 2002

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	Not reported	Operating Income: -7003000 Open source Revenue: 0 Open source
19951995-12-31	Operating margin	-70.1%	Operating Income: -3495000 Open source Revenue: 4985000 Open source
19961996-12-31	Operating margin	-20.7%	Operating Income: -2333000 Open source Revenue: 11273000 Open source
19971997-12-31	Operating margin	-47.5%	Operating Income: -7074000 Open source Revenue: 14894000 Open source
19981998-12-31	Operating margin	-103.7%	Operating Income: -11596000 Open source Revenue: 11181000 Open source
19991999-12-31	Operating margin	-124.9%	Operating Income: -11796000 Open source Revenue: 9448000 Open source
20002000-12-31	Operating margin	-248.5%	Operating Income: -14571000 Open source Revenue: 5864000 Open source
20012001-12-31	Operating margin	-268.1%	Operating Income: -28599000 Open source Revenue: 10666000 Open source
20022002-12-31	Operating margin	-488.6%	Operating Income: -42376000 Open source Revenue: 8673000 Open source
19941994-12-31	Net margin	Not reported	Net Income: -7034000 Open source Revenue: 0 Open source
19951995-12-31	Net margin	-70.5%	Net Income: -3516000 Open source Revenue: 4985000 Open source
19961996-12-31	Net margin	-5.9%	Net Income: -670000 Open source Revenue: 11273000 Open source
19971997-12-31	Net margin	-30.9%	Net Income: -4602000 Open source Revenue: 14894000 Open source
19981998-12-31	Net margin	-87.3%	Net Income: -9758000 Open source Revenue: 11181000 Open source
19991999-12-31	Net margin	-113.7%	Net Income: -10746000 Open source Revenue: 9448000 Open source
20002000-12-31	Net margin	-237.8%	Net Income: -13945000 Open source Revenue: 5864000 Open source
20012001-12-31	Net margin	-261.8%	Net Income: -27925000 Open source Revenue: 10666000 Open source
20022002-12-31	Net margin	-475.1%	Net Income: -41202000 Open source Revenue: 8673000 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6249000 Open source Capital Expenditure: 692000 Open source
19951995-12-31	Free cash flow margin	-27.3%	Revenue: 4985000 Open source Operating Cash Flow: -1215000 Open source Capital Expenditure: 148000 Open source
19961996-12-31	Free cash flow margin	-12.3%	Revenue: 11273000 Open source Operating Cash Flow: 4387000 Open source Capital Expenditure: 5779000 Open source
19971997-12-31	Free cash flow margin	-42.2%	Revenue: 14894000 Open source Operating Cash Flow: -2586000 Open source Capital Expenditure: 3702000 Open source
19981998-12-31	Free cash flow margin	-95.5%	Revenue: 11181000 Open source Operating Cash Flow: -7588000 Open source Capital Expenditure: 3089000 Open source
19991999-12-31	Free cash flow margin	-82.3%	Revenue: 9448000 Open source Operating Cash Flow: -7304000 Open source Capital Expenditure: 473000 Open source
20002000-12-31	Free cash flow margin	-209.8%	Revenue: 5864000 Open source Operating Cash Flow: -11525000 Open source Capital Expenditure: 779000 Open source
20012001-12-31	Free cash flow margin	-99.8%	Revenue: 10666000 Open source Operating Cash Flow: -9983000 Open source Capital Expenditure: 665000 Open source
20022002-12-31	Free cash flow margin	-289%	Revenue: 8673000 Open source Operating Cash Flow: -21453000 Open source Capital Expenditure: 3612000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -21.5M 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-6249000	Operating Cash Flow: -6249000 Open source
19951995-12-31	Operating cash flow	-1215000	Operating Cash Flow: -1215000 Open source
19961996-12-31	Operating cash flow	4387000	Operating Cash Flow: 4387000 Open source
19971997-12-31	Operating cash flow	-2586000	Operating Cash Flow: -2586000 Open source
19981998-12-31	Operating cash flow	-7588000	Operating Cash Flow: -7588000 Open source
19991999-12-31	Operating cash flow	-7304000	Operating Cash Flow: -7304000 Open source
20002000-12-31	Operating cash flow	-11525000	Operating Cash Flow: -11525000 Open source
20012001-12-31	Operating cash flow	-9983000	Operating Cash Flow: -9983000 Open source
20022002-12-31	Operating cash flow	-21453000	Operating Cash Flow: -21453000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -25.1M 2002

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-6941000	Operating Cash Flow: -6249000 Open source Capital Expenditure: 692000 Open source
19951995-12-31	Free cash flow	-1363000	Operating Cash Flow: -1215000 Open source Capital Expenditure: 148000 Open source
19961996-12-31	Free cash flow	-1392000	Operating Cash Flow: 4387000 Open source Capital Expenditure: 5779000 Open source
19971997-12-31	Free cash flow	-6288000	Operating Cash Flow: -2586000 Open source Capital Expenditure: 3702000 Open source
19981998-12-31	Free cash flow	-10677000	Operating Cash Flow: -7588000 Open source Capital Expenditure: 3089000 Open source
19991999-12-31	Free cash flow	-7777000	Operating Cash Flow: -7304000 Open source Capital Expenditure: 473000 Open source
20002000-12-31	Free cash flow	-12304000	Operating Cash Flow: -11525000 Open source Capital Expenditure: 779000 Open source
20012001-12-31	Free cash flow	-10648000	Operating Cash Flow: -9983000 Open source Capital Expenditure: 665000 Open source
20022002-12-31	Free cash flow	-25065000	Operating Cash Flow: -21453000 Open source Capital Expenditure: 3612000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
1995-12-31	Liabilities / assets	Not reported	Total Assets: 13493000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 56826000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 51782000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 44490000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 33831000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 27198000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 78044000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 46317000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.32× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	3.82×	Current Assets: 8655000 Open source Current Liabilities: 2267000 Open source
19961996-12-31	Current assets / current liabilities	9.03×	Current Assets: 47842000 Open source Current Liabilities: 5300000 Open source
19971997-12-31	Current assets / current liabilities	9.39×	Current Assets: 41671000 Open source Current Liabilities: 4436000 Open source
19981998-12-31	Current assets / current liabilities	9.62×	Current Assets: 33782000 Open source Current Liabilities: 3513000 Open source
19991999-12-31	Current assets / current liabilities	6.55×	Current Assets: 25311000 Open source Current Liabilities: 3864000 Open source
20002000-12-31	Current assets / current liabilities	1.82×	Current Assets: 20485000 Open source Current Liabilities: 11271000 Open source
20012001-12-31	Current assets / current liabilities	6.79×	Current Assets: 65455000 Open source Current Liabilities: 9637000 Open source
20022002-12-31	Current assets / current liabilities	4.32×	Current Assets: 36035000 Open source Current Liabilities: 8340000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 7.03 million Exact value Exact value: -7034000 USD 1994-01-01 – 1994-12-31: -7034000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 1994-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -7034000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7034000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-97-001506.txt#2906 The citation records this snapshot. The page link may show a newer release later.	−USD 6.25 million Exact value Exact value: -6249000 USD 1994-01-01 – 1994-12-31: -6249000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 1994-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -6249000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6249000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-97-001506.txt#2922 The citation records this snapshot. The page link may show a newer release later.	USD 692,000 Exact value Exact value: 692000 USD 1994-01-01 – 1994-12-31: 692000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 1994-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 692000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 692000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-97-001506.txt#2927 The citation records this snapshot. The page link may show a newer release later.	−USD 6.94 million Calculation and evidence -6249000 − 692000 USD Exact free cash flow: -6941000 USD 1994-01-01 – 1994-12-31: -6249000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 692000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 1994-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -6941000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6249000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-97-001506.txt#2922 Input fundies:CapitalExpenditure: 692000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-97-001506.txt#2927 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 3.52 million Exact value Exact value: -3516000 USD 1995-01-01 – 1995-12-31: -3516000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 1995-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -3516000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3516000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-98-001428.txt#2857 The citation records this snapshot. The page link may show a newer release later.	−USD 1.22 million Exact value Exact value: -1215000 USD 1995-01-01 – 1995-12-31: -1215000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 1995-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -1215000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1215000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-98-001428.txt#2874 The citation records this snapshot. The page link may show a newer release later.	USD 148,000 Exact value Exact value: 148000 USD 1995-01-01 – 1995-12-31: 148000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 1995-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 148000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 148000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-98-001428.txt#2880 The citation records this snapshot. The page link may show a newer release later.	−USD 1.36 million Calculation and evidence -1215000 − 148000 USD Exact free cash flow: -1363000 USD 1995-01-01 – 1995-12-31: -1215000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 148000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 1995-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -1363000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1215000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-98-001428.txt#2874 Input fundies:CapitalExpenditure: 148000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-98-001428.txt#2880 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 670,000 Exact value Exact value: -670000 USD 1996-01-01 – 1996-12-31: -670000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 1996-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -670000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -670000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000950150-99-000401.txt#2832 The citation records this snapshot. The page link may show a newer release later.	USD 4.39 million Exact value Exact value: 4387000 USD 1996-01-01 – 1996-12-31: 4387000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 1996-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: 4387000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4387000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000950150-99-000401.txt#2848 The citation records this snapshot. The page link may show a newer release later.	USD 5.78 million Exact value Exact value: 5779000 USD 1996-01-01 – 1996-12-31: 5779000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 1996-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 5779000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5779000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000950150-99-000401.txt#2854 The citation records this snapshot. The page link may show a newer release later.	−USD 1.39 million Calculation and evidence 4387000 − 5779000 USD Exact free cash flow: -1392000 USD 1996-01-01 – 1996-12-31: 4387000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 5779000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 1996-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -1392000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4387000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000950150-99-000401.txt#2848 Input fundies:CapitalExpenditure: 5779000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000950150-99-000401.txt#2854 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 4.6 million Exact value Exact value: -4602000 USD 1997-01-01 – 1997-12-31: -4602000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 1997-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -4602000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4602000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-00-001874.txt#3257 The citation records this snapshot. The page link may show a newer release later.	−USD 2.59 million Exact value Exact value: -2586000 USD 1997-01-01 – 1997-12-31: -2586000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 1997-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -2586000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2586000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-00-001874.txt#3271 The citation records this snapshot. The page link may show a newer release later.	USD 3.7 million Exact value Exact value: 3702000 USD 1997-01-01 – 1997-12-31: 3702000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 1997-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 3702000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3702000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-00-001874.txt#3277 The citation records this snapshot. The page link may show a newer release later.	−USD 6.29 million Calculation and evidence -2586000 − 3702000 USD Exact free cash flow: -6288000 USD 1997-01-01 – 1997-12-31: -2586000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 3702000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 1997-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -6288000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2586000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-00-001874.txt#3271 Input fundies:CapitalExpenditure: 3702000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-00-001874.txt#3277 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 9.76 million Exact value Exact value: -9758000 USD 1998-01-01 – 1998-12-31: -9758000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 1998-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -9758000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9758000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-01-000242.txt#4238 The citation records this snapshot. The page link may show a newer release later.	−USD 7.59 million Exact value Exact value: -7588000 USD 1998-01-01 – 1998-12-31: -7588000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 1998-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -7588000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7588000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-01-000242.txt#4252 The citation records this snapshot. The page link may show a newer release later.	USD 3.09 million Exact value Exact value: 3089000 USD 1998-01-01 – 1998-12-31: 3089000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 1998-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 3089000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3089000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-01-000242.txt#4258 The citation records this snapshot. The page link may show a newer release later.	−USD 10.68 million Calculation and evidence -7588000 − 3089000 USD Exact free cash flow: -10677000 USD 1998-01-01 – 1998-12-31: -7588000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 3089000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 1998-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -10677000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7588000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-01-000242.txt#4252 Input fundies:CapitalExpenditure: 3089000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000891618-01-000242.txt#4258 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 10.75 million Exact value Exact value: -10746000 USD 1999-01-01 – 1999-12-31: -10746000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 1999-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -10746000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10746000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0001021408-02-004489.txt#3444 The citation records this snapshot. The page link may show a newer release later.	−USD 7.3 million Exact value Exact value: -7304000 USD 1999-01-01 – 1999-12-31: -7304000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 1999-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -7304000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7304000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0001021408-02-004489.txt#3463 The citation records this snapshot. The page link may show a newer release later.	USD 473,000 Exact value Exact value: 473000 USD 1999-01-01 – 1999-12-31: 473000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 1999-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 473000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 473000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0001021408-02-004489.txt#3471 The citation records this snapshot. The page link may show a newer release later.	−USD 7.78 million Calculation and evidence -7304000 − 473000 USD Exact free cash flow: -7777000 USD 1999-01-01 – 1999-12-31: -7304000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 473000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 1999-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -7777000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7304000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0001021408-02-004489.txt#3463 Input fundies:CapitalExpenditure: 473000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0001021408-02-004489.txt#3471 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 13.95 million Exact value Exact value: -13945000 USD 2000-01-01 – 2000-12-31: -13945000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 2000-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -13945000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13945000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7129 The citation records this snapshot. The page link may show a newer release later.	−USD 11.53 million Exact value Exact value: -11525000 USD 2000-01-01 – 2000-12-31: -11525000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 2000-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -11525000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11525000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410 The citation records this snapshot. The page link may show a newer release later.	USD 779,000 Exact value Exact value: 779000 USD 2000-01-01 – 2000-12-31: 779000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 2000-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 779000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 779000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564 The citation records this snapshot. The page link may show a newer release later.	−USD 12.3 million Calculation and evidence -11525000 − 779000 USD Exact free cash flow: -12304000 USD 2000-01-01 – 2000-12-31: -11525000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 779000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 2000-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -12304000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11525000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410 Input fundies:CapitalExpenditure: 779000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 27.93 million Exact value Exact value: -27925000 USD 2001-01-01 – 2001-12-31: -27925000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 2001-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -27925000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27925000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7129 The citation records this snapshot. The page link may show a newer release later.	−USD 9.98 million Exact value Exact value: -9983000 USD 2001-01-01 – 2001-12-31: -9983000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 2001-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -9983000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9983000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410 The citation records this snapshot. The page link may show a newer release later.	USD 665,000 Exact value Exact value: 665000 USD 2001-01-01 – 2001-12-31: 665000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 2001-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 665000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 665000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564 The citation records this snapshot. The page link may show a newer release later.	−USD 10.65 million Calculation and evidence -9983000 − 665000 USD Exact free cash flow: -10648000 USD 2001-01-01 – 2001-12-31: -9983000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 665000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 2001-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -10648000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9983000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410 Input fundies:CapitalExpenditure: 665000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 41.2 million Exact value Exact value: -41202000 USD 2002-01-01 – 2002-12-31: -41202000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Net Income: -41202000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -41202000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7129 The citation records this snapshot. The page link may show a newer release later.	−USD 21.45 million Exact value Exact value: -21453000 USD 2002-01-01 – 2002-12-31: -21453000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Operating Cash Flow: -21453000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21453000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410 The citation records this snapshot. The page link may show a newer release later.	USD 3.61 million Exact value Exact value: 3612000 USD 2002-01-01 – 2002-12-31: 3612000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Capital Expenditure: 3612000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3612000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564 The citation records this snapshot. The page link may show a newer release later.	−USD 25.07 million Calculation and evidence -21453000 − 3612000 USD Exact free cash flow: -25065000 USD 2002-01-01 – 2002-12-31: -21453000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 3612000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ESSENTIAL THERAPEUTICS INC · 2002-12-31 ESSENTIAL THERAPEUTICS INC (edgar:1010915) Free cash flow: -25065000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:42:23Z Snapshot: c9dcf15ae2be56943611f20e82ceada7640439bd08855c7fc3dbb9d9391b5687 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1010915?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21453000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7410 Input fundies:CapitalExpenditure: 3612000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1010915/0000927016-03-001554.txt#7564 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001010915, 1010915, edgar:1010915

Also known as MICROCIDE PHARMACEUTICALS INC

ESSENTIAL THERAPEUTICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2002 2002-01-01 – 2002-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation